IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 50 filers reported holding IKENA ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,443,445 | -32.2% | 2,180,934 | +2.8% | 3.74% | -11.4% |
Q2 2023 | $13,920,582 | +142.9% | 2,122,040 | +27.8% | 4.22% | +177.7% |
Q1 2023 | $5,730,010 | +31.6% | 1,660,872 | +1.4% | 1.52% | +31.1% |
Q4 2022 | $4,355,409 | +1.0% | 1,637,372 | +34.8% | 1.16% | +0.1% |
Q3 2022 | $4,311,000 | -10.8% | 1,214,304 | +11.3% | 1.16% | -37.2% |
Q2 2022 | $4,833,000 | -2.8% | 1,090,937 | +33.9% | 1.85% | -12.6% |
Q1 2022 | $4,970,000 | -51.4% | 814,755 | -0.0% | 2.11% | -37.7% |
Q4 2021 | $10,217,000 | +157.0% | 814,756 | +158.7% | 3.39% | +192.3% |
Q3 2021 | $3,975,000 | -65.3% | 315,000 | -61.3% | 1.16% | -56.4% |
Q2 2021 | $11,440,000 | -50.3% | 814,756 | 0.0% | 2.66% | -42.3% |
Q1 2021 | $23,017,000 | – | 814,756 | – | 4.61% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 5,018,178 | $62,928,000 | 5.78% |
Omega Fund Management, LLC | 2,249,123 | $28,204,000 | 3.99% |
CHI Advisors LLC | 814,756 | $10,217,000 | 3.39% |
BVF INC/IL | 1,798,371 | $22,552,000 | 0.82% |
Artal Group S.A. | 1,549,513 | $19,431,000 | 0.53% |
Orbimed Advisors | 2,933,941 | $36,792,000 | 0.47% |
Logos Global Management LP | 299,853 | $3,760,000 | 0.39% |
HealthCor Management, L.P. | 287,621 | $3,607,000 | 0.20% |
RA Capital Management | 750,000 | $9,405,000 | 0.17% |
FARALLON CAPITAL MANAGEMENT LLC | 1,081,309 | $13,560,000 | 0.07% |